Knight Therapeutics completed the acquisition of International Pharmaceuticals business from Endo for $105m.

Synopsis

Knight Therapeutics, a specialty pharmaceutical company, completed the acquisition of International Pharmaceuticals business from Endo, a pharmaceutical company, for $105m.

Principals

target

Endo (international Pharmaceuticals Business)

bidder

Knight Therapeutics

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context